Microbiome Testing Kit Market Report 2025

The microbiome testing kit market size has grown exponentially in recent years. It will grow from $1.31 billion in 2024 to $1.63 billion in 2025 at a compound annual growth rate (CAGR) of 24.5%. The growth in the historic period is attributed to increasing public focus on digestive wellness, rising adoption of nutrigenomics testing, growing consumer awareness of microbiome functions, expansion of preventive healthcare campaigns, and higher prevalence of lifestyle-related diseases.

The microbiome testing kit market size is expected to see exponential growth in the next few years. It will grow to $3.88 billion in 2029 at a compound annual growth rate (CAGR) of 24.1%. The growth in the forecast period is driven by rising demand for personalized medicine, greater adoption of at-home self-testing, increasing prevalence of gut-brain related disorders, higher investment in microbiome therapeutics, and growing demand for evidence-based medicine and precision therapeutics. Key trends in the forecast period include advancements in next-generation sequencing technologies, integration with mobile health applications, innovation in AI-driven microbiome analytics, development of rapid home testing kits, and progress in standardized clinical reporting tools.

The rising demand for personalized medicine is anticipated to drive growth in the microbiome testing kit market in the coming years. Personalized medicine customizes treatment and prevention strategies based on an individual’s unique genetic profile, lifestyle, and environment. This approach has gained traction largely due to advancements in genomics, which allow for the accurate identification of genetic differences and individualized treatments. Microbiome testing kits support personalized medicine by delivering detailed insights into a person’s microbial makeup, making them valuable for tailored health management. These kits reduce uncertainty in dietary and lifestyle adjustments by offering precise, data-driven advice that enhances overall health and helps prevent diseases. For example, in February 2024, the Personalized Medicine Coalition (PMC), a US nonprofit, reported that the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, compared to 12 in 2022. This growing demand for personalized medicine is thus contributing to the expansion of the microbiome testing kit market.

Leading companies in the microbiome testing kit industry are developing innovative products such as next-generation sequencing-based gut microbiome analysis to deliver personalized gut health insights and dietary recommendations. This technique rapidly decodes the DNA of all gut microbes to determine their types, abundance, and possible effects on health. For instance, in January 2025, CJ Bioscience Inc., a biotechnology firm from South Korea, introduced SMILE GUT, a direct-to-consumer gut microbiome test that provides personalized gut health information. The kit uses next-generation sequencing combined with artificial intelligence to analyze stool samples and produces a gut microbiome index score that measures microbial diversity, the balance between beneficial and harmful bacteria, and conformity with healthy gut profiles. It offers customized health advice, including probiotic and dietary recommendations, with results available within 14 business days, enabling users to better manage their gut health.

In January 2025, Pooch and Mutt Ltd., a pet food and treat company based in the UK, acquired Biome9 for an undisclosed sum. This acquisition allows Pooch and Mutt to enhance its science-driven pet nutrition products by delivering personalized, microbiome-based gut health solutions for dogs. Biome9 Limited, also UK-based, provides a microbiome testing kit designed specifically for dogs called the gutdiscovery test.

Major players in the microbiome testing kit market are OraSure Technologies Inc., Genova Diagnostics Inc., Ombre Health Inc., Viome Inc., Zymo Research Corporation, EasyDNA Pty Ltd., Psomagen Inc., DayTwo Ltd., Atlas Biomed Group Limited., BIOHM Health Inc., Mapmygenome India Limited, Biomes NGS GmbH, Carbiotix AB, CosmosID Inc., Juno Bio Ltd., Microba Life Sciences Limited., Sun Genomics Inc., Unseen Bio ApS, InnerBuddies, and MyMicroZoo B.V.

North America was the largest region in the personalized genomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in microbiome testing kit report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the microbiome testing kit market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

A microbiome testing kit is a diagnostic tool designed to analyze microbial communities, including bacteria, viruses, and fungi, in a specific environment such as the human gut, skin, or oral cavity. These kits provide insights into an individual’s microbiome composition, supporting assessments of health, nutrition, and potential disease risk factors.

The primary product types of microbiome testing kits are at-home testing kits and laboratory-based testing kits. At-home testing kits allow individuals to collect and analyze gut or other body microbiota samples from home, offering personalized insights into microbial composition, diversity, and overall health. They utilize various sample types, including stool, saliva, and skin, and are applied in areas such as gut health, skin health, nutrition and diet, disease risk assessment, and other applications. Distribution channels include online pharmacies, retail stores, and other outlets. Key end-users include individuals, hospitals and clinics, research and academic institutes, and related organizations.

The microbiome testing kit market research report is one of a series of new reports that provides microbiome testing kit market statistics, including microbiome testing kit industry global market size, regional shares, competitors with a microbiome testing kit market share, detailed microbiome testing kit market segments, market trends and opportunities, and any further data you may need to thrive in the microbiome testing kit industry. This microbiome testing kit market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The microbiome testing kit market consists of sales of respiratory microbiome kits, infant microbiome kits, environmental microbiome kits, sample preservation and transport kits, next-generation sequencing (NGS) panels, and data interpretation platforms. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.